Stockholder’s Equity | Note 14. Stockholder’s Equity Authorized Capital Stock Effective July 3, 2023, the Company filed an Amended and Restated Certificate of Incorporation to amend its authorized capital stock to authorize the Company to issue 215,000,000 The Company has authorized 5,000,000 0.0001 The Company has authorized 210,000,000 0.0001 200,000,000 10,000,000 The Class B Common Stock is entitled to 10 votes for every 1 vote of the Class A Common Stock. Series A Convertible Preferred Stock On October 11, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to issue and sell to such investor, in a registered direct offering (the “Offering”), an aggregate of 2,000 0.0001 1,000 1,000 10.152 10.152 During the six months ended June 30, 2024, 372 27,374 106,748 The Company had 0 372 Class A Common Stock The Company had 4,081,344 983,173 Fiscal year 2024 On January 29, 2024, the Company entered into a public offering of an aggregate of 1,181,900 69,900 5,632,650 5,008,259 On February 29, 2024, the Company entered into a public offering of an aggregate of 1,321,000 Shares 7,926,000 7,102,527 During the six months ended June 30, 2024, 372 58,941 106,748 During the six months ended June 30, 2024, 418,724 1,631,524 Class B Common Sock The Company had 100,000 Warrants During the period ended June 30, 2024, the Company issued 200 five years 100 January 2024 offering The Company issued a total of 69,900 five years 4.50 62,585 five years 5.625 February 2024 offering The Company issued a total of 66,050 five years 7.50 A summary of activity of the warrants during the six months ended June 30, 2024 as follows: Schedule of Activity of Warrant Number of Weighted average Average shares Exercise Price Life (years) Outstanding, December 31, 2023 233,816 $ 13.22 4.73 Granted 69,900 4.50 5.00 Granted 200 100.00 5.00 Granted 62,585 5.63 5.00 Granted 66,050 7.50 5.00 Split – warrant granted in October 2023 316,286 3.90 - Exercised (488,624 ) 3.98 - Outstanding, June 30, 2024 260,213 $ 8.94 4.40 Exercisable, June 30, 2024 131,578 $ 11.24 4.18 The intrinsic value of the warrants as of June 30, 2024 is $ 0 Stock Options On February 6, 2024, the Company granted 25,000 4.12 5 Options issued vest at 33% of shares subject to the option on each anniversary date, on February 6, 2025, 2026 and 2027 The Company utilizes the Black-Scholes model to value its stock options. The Company utilized the following assumptions: Schedule of Utilizes Black-Scholes Model to Value of Stock Options Six months ended June 30, 2024 Expected term 3.50 Expected average volatility 187 % Expected dividend yield - Risk-free interest rate 4.14 % During the six months ended June 30, 2024, the Company granted 25,000 95,325 86,044 543,174 533,892 64,752 0 A summary of activity of the stock options during the six months ended June 30, 2024, is as follows: Schedule of Activity of Stock Options Options Outstanding Weighted Number of Weighted Average Average Remaining life Options Exercise Price (years) Outstanding, December 31, 2023 39,752 $ 16.42 4.33 Granted 25,000 $ 4.12 5.00 Exercised - - - Forfeited/canceled - - - Outstanding, June 30, 2024 64,752 $ 11.67 4.33 Exercisable options, June 30, 2024 200 $ 100.00 4.32 |